Coherus BioSciences will see its workforce shrink once again as the result of the recently agreed sale of its Neulasta ...
Q4 2024 Earnings Call Transcript March 10, 2025 Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback